data13F

Theravance Biopharma Inc

Held by 0 of 60 tracked investors in their latest 13F filing

Investors holding0
Combined shares0
Combined reported value$0

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Paul Tudor Jones0.00Closed0–Q3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view Closed00.00
Q2 2026Paul Tudor Jones narrow view Reduced 49.7%60,4250.00
Q1 2026Paul Tudor Jones narrow view Reduced 36.8%120,1220.01
Q4 2025Paul Tudor Jones narrow view Added 272.5%190,1290.01

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q4 2025Paul Tudor Jones narrow view Added 272.5%190,1290.01

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view Closed00.00
Q2 2026Paul Tudor Jones narrow view Reduced 49.7%60,4250.00
Q1 2026Paul Tudor Jones narrow view Reduced 36.8%120,1220.01

History

3 peakQ2 2026: 1 tracked investors
Q2 2014: 1 tracked investorsQ3 2014: 1 tracked investorsQ4 2014: 1 tracked investorsQ1 2015: 1 tracked investorsQ2 2015: 2 tracked investorsQ3 2015: 1 tracked investorsQ4 2015: 1 tracked investorsQ1 2016: 1 tracked investorsQ2 2016: 1 tracked investorsQ3 2016: 1 tracked investorsQ4 2016: 1 tracked investorsQ1 2017: 1 tracked investorsQ2 2017: 1 tracked investorsQ3 2017: 1 tracked investorsQ4 2017: 1 tracked investorsQ1 2018: 1 tracked investorsQ2 2018: 1 tracked investorsQ3 2018: 1 tracked investorsQ4 2018: 1 tracked investorsQ1 2019: 1 tracked investorsQ2 2019: 1 tracked investorsQ3 2019: 1 tracked investorsQ4 2019: 1 tracked investorsQ1 2020: 1 tracked investorsQ2 2020: 1 tracked investorsQ3 2020: 1 tracked investorsQ4 2020: 1 tracked investorsQ1 2021: 1 tracked investorsQ2 2021: 1 tracked investorsQ3 2021: 2 tracked investorsQ4 2021: 2 tracked investorsQ1 2022: 3 tracked investorsQ2 2022: 3 tracked investorsQ3 2022: 1 tracked investorsQ4 2022: 2 tracked investorsQ1 2023: 2 tracked investorsQ2 2023: 2 tracked investorsQ3 2023: 2 tracked investorsQ4 2023: 2 tracked investorsQ1 2024: 2 tracked investorsQ2 2024: 2 tracked investorsQ3 2024: 1 tracked investorsQ4 2024: 1 tracked investorsQ1 2025: 1 tracked investorsQ2 2025: 1 tracked investorsQ3 2025: 1 tracked investorsQ4 2025: 1 tracked investorsQ1 2026: 1 tracked investorsQ2 2026: 1 tracked investors
20142026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Paul Tudor Jones–60.4K120.1K190.1K51.0K196.6K196.6K196.6K

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).